189 related articles for article (PubMed ID: 30327788)
1. Predictors of Mortality Among a National Cohort of Veterans With Recurrent
Appaneal HJ; Caffrey AR; Beganovic M; Avramovic S; LaPlante KL
Open Forum Infect Dis; 2018 Aug; 5(8):ofy175. PubMed ID: 30327788
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Clostridioides difficile recurrence across a national cohort of veterans in outpatient, acute, and long-term care settings.
Appaneal HJ; Caffrey AR; Beganovic M; Avramovic S; LaPlante KL
Am J Health Syst Pharm; 2019 Apr; 76(9):581-590. PubMed ID: 31361830
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
Freedberg DE; Salmasian H; Friedman C; Abrams JA
Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
[TBL] [Abstract][Full Text] [Related]
4. What Is the Role for Metronidazole in the Treatment of Clostridium difficile Infection? Results From a National Cohort Study of Veterans With Initial Mild Disease.
Appaneal HJ; Caffrey AR; LaPlante KL
Clin Infect Dis; 2019 Sep; 69(8):1288-1295. PubMed ID: 30561531
[TBL] [Abstract][Full Text] [Related]
5. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
McDonald EG; Milligan J; Frenette C; Lee TC
JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
[TBL] [Abstract][Full Text] [Related]
6. National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014.
Reveles KR; Lawson KA; Mortensen EM; Pugh MJV; Koeller JM; Argamany JR; Frei CR
PLoS One; 2017; 12(12):e0189227. PubMed ID: 29216276
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection.
Stevens VW; Nelson RE; Schwab-Daugherty EM; Khader K; Jones MM; Brown KA; Greene T; Croft LD; Neuhauser M; Glassman P; Goetz MB; Samore MH; Rubin MA
JAMA Intern Med; 2017 Apr; 177(4):546-553. PubMed ID: 28166328
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
Ramanathan S; Johnson S; Burns SP; Kralovic SM; Goldstein B; Smith B; Gerding DN; Evans CT
Am J Infect Control; 2014 Feb; 42(2):168-73. PubMed ID: 24485372
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.
Fischer M; Kao D; Mehta SR; Martin T; Dimitry J; Keshteli AH; Cook GK; Phelps E; Sipe BW; Xu H; Kelly CR
Am J Gastroenterol; 2016 Jul; 111(7):1024-31. PubMed ID: 27185076
[TBL] [Abstract][Full Text] [Related]
11. Derivation and Validation of a Clostridium difficile Infection Recurrence Prediction Rule in a National Cohort of Veterans.
Reveles KR; Mortensen EM; Koeller JM; Lawson KA; Pugh MJV; Rumbellow SA; Argamany JR; Frei CR
Pharmacotherapy; 2018 Mar; 38(3):349-356. PubMed ID: 29393522
[TBL] [Abstract][Full Text] [Related]
12. Factors Predicting Recurrence of Clostridium difficile Infection (CDI) in Hospitalized Patients: Retrospective Study of More Than 2000 Patients.
Abdelfatah M; Nayfe R; Nijim A; Enriquez K; Ali E; Watkins RR; Kandil H
J Investig Med; 2015 Jun; 63(5):747-51. PubMed ID: 25871748
[TBL] [Abstract][Full Text] [Related]
13. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
Blumberg EA; Collins G; Young JH; Nguyen MH; Michonneau D; Temesgen Z; Origȕen J; Barcan L; Obeid KM; Belloso WH; Gras J; Corbelli GM; Neaton JD; Lundgren J; Snydman DR; Molina JM;
Transpl Infect Dis; 2022 Feb; 24(1):e13770. PubMed ID: 34821423
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections.
Carignan A; Poulin S; Martin P; Labbé AC; Valiquette L; Al-Bachari H; Montpetit LP; Pépin J
Am J Gastroenterol; 2016 Dec; 111(12):1834-1840. PubMed ID: 27619835
[TBL] [Abstract][Full Text] [Related]
15. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
[TBL] [Abstract][Full Text] [Related]
16. Clinical predictors of recurrent Clostridium difficile infection in out-patients.
Shivashankar R; Khanna S; Kammer PP; Scott Harmsen W; Zinsmeister AR; Baddour LM; Pardi DS
Aliment Pharmacol Ther; 2014 Sep; 40(5):518-22. PubMed ID: 25039269
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Clostridium difficile infection is associated with increased mortality.
Olsen MA; Yan Y; Reske KA; Zilberberg MD; Dubberke ER
Clin Microbiol Infect; 2015 Feb; 21(2):164-70. PubMed ID: 25658560
[TBL] [Abstract][Full Text] [Related]
18. An Observational Cohort Study of
Rao K; Higgins PDR; Young VB
mSphere; 2018; 3(3):. PubMed ID: 29794054
[TBL] [Abstract][Full Text] [Related]
19. Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics.
van Beurden YH; Nezami S; Mulder CJJ; Vandenbroucke-Grauls CMJE
Clin Microbiol Infect; 2018 Jan; 24(1):85.e1-85.e4. PubMed ID: 28782647
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Community and Healthcare-onset Clostridium difficile Infections.
Mora Pinzon MC; Buie R; Liou JI; Shirley DK; Evans CT; Ramanathan S; Poggensee L; Safdar N
Clin Infect Dis; 2019 Apr; 68(8):1343-1350. PubMed ID: 30668844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
